SCHEMBL16612857

SCHEMBL16612857

COc1cccc(OCCn2c[c]c(C(N)=O)n2)c1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MTNR1A P48039 3/20 0.44
MTNR1B P49286 3/20 0.44
DRD2 P14416 1/20 0.44
DRD3 P35462 1/20 0.44
KDM4E B2RXH2 3/20 0.44
ALDH1A1 P00352 3/20 0.44
KMT2A Q03164 1/20 0.44
PKM P14618 1/20 0.43
LMNA P02545 2/20 0.43
GAA P10253 2/20 0.42
PARP1 P09874 1/20 0.42
NPC1 O15118 1/20 0.41
TP53 P04637 1/20 0.41
RECQL P46063 1/20 0.41
RAB9A P51151 1/20 0.41
MAPK10 P53779 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
TDP1 Q9NUW8 2/20 0.41
TSHR P16473 1/20 0.41
MAPK1 P28482 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16612828 0.86 SIRT2 (0.39) DRD2KMT2ALMNAPARP1SMN1; SMN2
SCHEMBL16612943 0.84 SIGMAR1 (0.47) MTNR1AMTNR1BPARP1HRH3
SCHEMBL16612866 0.78 HCRTR2 (0.41) KDM4EMAPK10
SCHEMBL16612712 0.78 HCRTR2 (0.38) ALDH1A1LMNAGAASMN1; SMN2TDP1
SCHEMBL16612782 0.77 HCRTR2 (0.39) PARP1HTR1A
SCHEMBL16612880 0.76 DRD2 (0.45) DRD2DRD3KDM4EALDH1A1KMT2A
SCHEMBL16613032 0.76 HCRTR2 (0.44)
SCHEMBL16612856 0.75 MTNR1A (0.54) MTNR1AMTNR1BKDM4EALDH1A1MAPK10
SCHEMBL16612990 0.74 HCRTR2 (0.39) ALDH1A1PKM
SCHEMBL16612868 0.74 MTNR1A (0.49) MTNR1AMTNR1BALDH1A1LMNANPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2675801-B1 NOVEL PYRAZOLE AND IMIDAZOLE DERIVATIVES USEFUL AS OREXIN ANTAGONISTS ACTELION PHARMACEUTICALS LTD (CH) 2015-04-08 EP claimed